RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment
2024 · Nature Communications · 26 citations
https://doi.org/10.1038/s41467-024-51571-8
Z
Zhiqiang Zhao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
83
Papers
545
Citations
12
h-index
17
i10-index
Zhiqiang Zhao is an academic researcher from Shenyang Pharmaceutical University. The author has contributed to research in topics: Atrial Fibrillation Management and Outcomes & Cardiac Arrhythmias and Treatments & Traditional Chinese Medicine Studies. The author has an h-index of 12, co-authored 71 publications.
ORCID: 0000-0002-7615-6437Papers by this author
worksBoosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury
2025 · Nature Communications · 8 citations
https://doi.org/10.1038/s41467-025-61688-z
Effect of Qishen Yiqi dripping pills on the classification of ejection fraction in patients with ischaemic heart failure: A prospective cohort study
2025 · Phytomedicine · 6 citations
https://doi.org/10.1016/j.phymed.2025.156530
Molecularly Self‐Fueled Nano-Penetrator for Nonpharmaceutical Treatment of Thrombosis and Ischemic Stroke
2023 · Figshare · 2 citations
https://doi.org/10.6084/m9.figshare.21801139
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat